350 Participants Needed

Nurse-Led Telemonitoring for Chronic Conditions

Recruiting at 4 trial locations
ES
TA
DN
Overseen ByDenise Ng, MHI
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University Health Network, Toronto
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

The trial aims to test a new approach for assisting individuals with complex chronic conditions such as heart failure, diabetes, or depression. It focuses on telemonitoring, using a smartphone app to track symptoms and send alerts to healthcare providers when necessary. This method could enhance care coordination and ensure patients receive needed assistance between doctor's visits. Individuals who have been hospitalized and have one of these chronic conditions might be suitable candidates, particularly if they can use a smartphone app to monitor their health. As an unphased trial, this study offers participants the chance to contribute to innovative healthcare solutions and improve their own care management.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, as the trial focuses on telemonitoring for chronic conditions.

What prior data suggests that telemonitoring is safe for managing chronic conditions?

Research has shown that telemonitoring is generally safe for managing long-term health conditions. Studies have found that telemonitoring can lower the risk of death and hospital visits for patients with heart failure. By monitoring symptoms and notifying healthcare providers when necessary, it allows for quick action.

A review of multiple studies found that patients using telemonitoring devices often experience better outcomes, such as lower death rates, compared to those who do not use them. This suggests the technology is not only effective but also well-accepted by patients.

While every treatment has potential risks, current evidence indicates that telemonitoring is a safe option for managing chronic diseases like heart failure, diabetes, and COPD (chronic obstructive pulmonary disease). Those considering joining a trial involving telemonitoring can feel confident about its safety based on past research findings.12345

Why are researchers excited about this trial?

Researchers are excited about telemonitoring for chronic conditions because it offers a new way to manage multiple health issues like heart failure, diabetes, depression, hypertension, and COPD using a smartphone app. Unlike traditional treatments that rely on regular in-person visits to track symptoms and adjust care, this approach allows patients to monitor and report their symptoms daily from home. The app, Medly MCC, sends this data wirelessly to healthcare providers, who can respond promptly if needed, and provides patients with personalized self-care messages. This could lead to faster, more personalized care and better health outcomes by catching potential problems early.

What evidence suggests that telemonitoring is effective for managing chronic conditions?

This trial will compare a nurse-led telemonitoring system, specifically the Medly MCC, with standard care. Research has shown that telemonitoring systems like the Medly MCC can help manage long-term health issues. Studies have found that using telemonitoring can lower the chances of death and hospital visits for people with heart failure. It also helps track conditions like diabetes, high blood pressure, and COPD, allowing for quick medical responses. Specifically, people with chronic heart failure who use this technology have shown lower death rates. This system enables healthcare providers to monitor symptoms daily and alerts them when medical help might be needed, improving overall patient care.23678

Who Is on the Research Team?

ES

Emily Seto, PhD

Principal Investigator

University of Toronto

Are You a Good Fit for This Trial?

The SMaRT Study is for adults over 18 who have recently been discharged from certain hospitals in Canada and have at least one chronic condition like heart failure, COPD, high blood pressure, diabetes, or depression. Participants need to be able to use the telemonitoring app and devices (like a weight scale) and speak English or have someone who can communicate for them.

Inclusion Criteria

Discharged from hospital or seen within 48 hours of discharge at Health Sciences North (HSN), William Osler Health Systems (WOHS), Women's College Hospital (WCH), and Markham Stouffville Hospital (MSH)
I have a chronic condition like heart failure or diabetes that could improve with telemonitoring.
Able to comply with use of the telemonitoring application and applicable peripheral devices (e.g., able to stand on the weight scale, able to answer symptom questions, etc.)
See 1 more

Exclusion Criteria

Patients who are discharged from hospital with the intent to be admitted to a long-term care facility will be excluded

Timeline for a Trial Participant

Design and Development

Design and development of the SMaRT Clinic model and telemonitoring system

2 years

Implementation and Effectiveness Evaluation

Implementation of the SMaRT Clinics and evaluation of their effectiveness through various research activities

2 years

Follow-up

Participants are monitored for safety and effectiveness after treatment

1 year

What Are the Treatments Tested in This Trial?

Interventions

  • Telemonitoring
Trial Overview This study tests the SMaRT Clinic model which uses nurse-led care coordinated through telemonitoring to manage patients with multiple chronic conditions after they leave the hospital. It aims to improve self-care education and clinical coordination across patient care teams.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Telemonitoring (Medly MCC)Experimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University Health Network, Toronto

Lead Sponsor

Trials
1,555
Recruited
526,000+

Markham Stouffville Hospital

Collaborator

Trials
4
Recruited
2,500+

Health Sciences North

Collaborator

Trials
6
Recruited
1,100+

William Osler Health System

Collaborator

Trials
11
Recruited
36,100+

Women's College Hospital

Collaborator

Trials
108
Recruited
43,700+

Published Research Related to This Trial

In a randomized clinical trial involving 316 elderly heart failure patients, supplementing nurse case management with Internet-connected telemonitoring did not significantly reduce hospitalizations, emergency department visits, or mortality compared to case management alone.
Despite the lack of difference in the primary outcomes, participants in the telemonitoring group had 42% fewer inpatient days during the intervention compared to the previous year, highlighting the potential benefits of case management in managing heart failure.
Telemonitoring with case management for seniors with heart failure.Wade, MJ., Desai, AS., Spettell, CM., et al.[2022]
Telemonitoring allows older patients to record and send vital signs like blood pressure and pulse to nurses remotely, helping to identify health issues early and potentially prevent hospital admissions.
This method of care is generally well-received by patients and has shown promise in improving clinical outcomes, but nurses need to be trained to effectively use telemonitoring to maximize its benefits.
The role of telemonitoring in caring for older people with long-term conditions.Barrett, D.[2016]
Nurse-led telephone counseling significantly improved health behaviors and self-care for hypertension in low-income older adults, with a medium effect size (Cohen's d = 1.16) after 8 weeks.
The intervention also led to a reduction in systolic blood pressure (Cohen's d = -0.61), suggesting that personalized support can enhance health outcomes in disadvantaged populations using telemonitoring systems.
Telephone Support and Telemonitoring for Low-Income Older Adults.Jeong, S., Choi, H., Gwon, SH., et al.[2018]

Citations

A Systematic Review of Internet-Based Remote Patient ...Abbreviations: RCT, Randomized Controlled Trial; COPD, Chronic Obstructive Pulmonary Disease; DM, Diabetes Mellitus; HT, Hypertension; TIA, ...
Benefits and Challenges of Remote Patient Monitoring as ...For example, in a patient with a common diagnosis, such as chronic heart failure, who is monitored remotely through telemonitoring applications, ...
Telehealth care and remote monitoring strategies in heart ...This meta-analysis provides insights about telemonitoring on heart failure patients. Telemonitoring reduces mortality and rehospitalization in hearth failure ...
A systematic review of the impacts of remote patient ...observed lower death risks in telemonitored patients, and Wintrich et al. noted reduced cardiovascular death risks in chronic heart failure ...
Interactive Remote Patient Monitoring Devices for ...Cardiovascular disease, diabetes mellitus, and chronic obstructive pulmonary disease (COPD) are the most common chronic conditions worldwide [ ...
Interactive Remote Patient Monitoring Devices for Managing ...Cardiovascular disease, diabetes mellitus, and chronic obstructive pulmonary disease (COPD) are the most common chronic conditions worldwide [4]. Lack of care ...
The State of Remote Patient Monitoring for Chronic ...Patients with chronic illnesses, such as congestive heart failure, advanced kidney disease, advanced liver disease, hypertension, and diabetes ...
Remote Monitoring in Heart Failure: Patient Management ...Effectiveness of remote patient monitoring after discharge of hospitalized patients with heart failure: BEAT-HF. JAMA Intern Med 2016;176:310–8.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security